Medrogestone

• Description :

  Medrogestone is a new orally active Progestin. Medrogestone shows a marked local progestational effect. Medrogestone maintains pregnancy in ovariectomized rats. Medrogestone inhibits ovulation. Medrogestone prevents pregnancy. Medrogestone produces a significant reduction in the severity of benign prostatic hypertrophy[1][2].

• CAS Number :

  [977-79-7]

• UNSPSC :

  12352211

• Hazard Statement :

  H315-H319-H320

• Target :

  Progesterone Receptor

• Related Pathways :

  Vitamin D Related/Nuclear Receptor

• Field of Research :

  Endocrinology

• Smiles :

  CC([C@@]1(C)CC[C@@]2([H])[C@]3([H])C=C(C)C4=CC(CC[C@]4(C)[C@@]3([H])CC[C@]12C)=O)=O

• Molecular Formula :

  C23H32O2

• Molecular Weight :

  340.50

• Precautions :

  P264-P280-P302+P352-P305+P351+P338-P362

• References & Citations :

  [1]Revesz C, et al. Biological activity of medrogestone: a new orally active progestin. J Reprod Fertil. 1966 Dec;12 (3) :473-87. |[2]Rangno RE, et al. Treatment of benign prostatic hypertrophy with medrogestone. Clin Pharmacol Ther. 1971 Jul-Aug;12 (4) :658-65.

• Shipping Conditions :

  Room temperature

• Scientific Category :

  Reference compound1

• Clinical Information :

  Launched